Press Releases

Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to investigate the activity of its lead clinical program, ST101, in specialized tumor models developed by the NCI. ST101, a first-in-class peptide antagonist of C/EBPβ is

Colorado Biolabs, Inc. (CBL) and MFB Fertility, Inc. (MFB) are pleased to announce a strategic alliance granting MFB Fertility US distribution rights to Proferrin® Heme Iron Polypeptide, a unique form of iron, for future Proov® brand products. "As the leader in urine PdG testing to confirm ovulation, we believe MFB Fertility has a great track record of bringing innovative products to market.  We look forward to helping their group bring a highly effective iron supp

WuXi Biologics, a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered into an exclusive contract development and manufacturing partnership for OncoC4's full pipeline of biologics including its late-stage project, ONC-392, a next generation CTLA-4 antibody which is under phase I clinical trials in the U.S. and China. Per the agreement,

Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma, another renowned supplier. Vitamin K2 is an essential nutrient for optimal bone and cardiovascular health, but the modern diet does not include sufficient quantities of it. Only a few foods are naturally high in vitamin K2, such as natto, a Japanese fermented soybean dish, and these are not a mainstream part of diets in the United States or elsewhere. As a result, s

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased new land as part of a $17 million investment into its Conshohocken, PA site. The new 4-acre plot is directly adjacent to Sharp’s two existing commercial pharmaceutical packaging buildings, which collectively form the organization’s Blistering Centre of Excellence and is the latest addition to an ongoing capacity expansion project at the Conshohocken campus

Scholar Rock, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for apitegromab, a selective inhibitor of myostatin activation, for the treatment of patients with Spinal Muscular Atrophy (SMA). Fast Track designation is intended to facilitate the development and expedite the review of drugs to treat s

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna COVID-19 Vaccine and additional programs in Moderna’s clinical development pipeline. Specifically, Aldevron will supply plasm

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Understanding (MoU) with the government of South Korea: one MoU with the Korea National Institute of Health (KNIH), an agency of the Korea Centers for Disease Control and Prevention Agency (KDCA) for a new collaboration on mRNA vaccine research in South Korea; and an additional MoU with the Ministry of Trade, Industry and Energy of the Republic of Korea (MOTIE), t

USANA Health Sciences, Inc., and its subsidiary in China—BabyCare, Ltd.—announced this week a research collaboration agreement with Beijing University of Chinese Medicine (BUCM), a well-known university in China. Under the agreement, USANA and BUCM will cooperatively research the field of Traditional Chinese Medicine (TCM). The objective of this collaboration is to bring together modern nutritional science and TCM to improve the health and wellness of individuals and families arou

Takeda Pharmaceutical Company Limited announced that the Ministry of Health, Labour and Welfare (MHLW) granted special approval under article 14-3 of the Pharmaceuticals and Medical Devices Act for emergency use of Moderna’s mRNA COVID-19 vaccine, TAK-919, now known as COVID-19 Vaccine Moderna Intramuscular Injection, in Japan. The approval is based on positive clinical data from Takeda’s Phase 1/2 immunogenicity and safety clinical trial of Moderna’s COVID-19 vaccine in Jap